Neil Exter - 30 Jan 2025 Form 3 Insider Report for Maze Therapeutics, Inc. (MAZE)

Role
Director
Signature
/s/ Courtney Phillips, as attorney-in-fact
Issuer symbol
MAZE
Transactions as of
30 Jan 2025
Net transactions value
$0
Form type
3
Filing time
30 Jan 2025, 16:29:38 UTC
Previous filing
21 Jun 2022
Next filing
19 Aug 2025

No securities are beneficially owned.